Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-28Clinical Trial Update: Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma [Phase 2]
A Phase 2 trial comparing RAD001 (everolimus) with sunitinib as first-line and second-line therapy for metastatic renal cell carcinoma has c…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer [Phase 2]
Phase 2 trial investigating chemotherapy followed by ESO-1 lymphocytes and aldesleukin in metastatic cancer was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy [Phase 3]
Phase 3 study evaluating bevacizumab (Avastin) added to interferon alfa-2a in metastatic renal cell carcinoma after nephrectomy; trial statu…
-
CLINICAL_TRIALS trial_result · 2016-06-13Clinical Trial Update: Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of temsirolimus and vinorelbine ditartrate in adults with unresectable or metastatic solid tumors…
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 clinical trial evaluating everolimus as second-line therapy in metastatic renal cell carcinoma has been completed, with results post…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Multicenter Dose-escalation Study of a Combination of Pazopanib and Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors [Phase 1]
Completed Phase 1 multicenter dose-escalation study evaluating the combination of pazopanib and bevacizumab in patients with metastatic rena…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients. [Phase 2]
A Phase 2, one-arm exploratory trial evaluating apatinib in patients with advanced/metastatic renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy with prednisone for recurrent/metastatic kidney cancer has completed. The study status is …
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer [Phase 2]
Phase 2 trial of sunitinib malate in patients with non-clear cell renal cell carcinoma has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025) [Phase 3]
A Phase 3 trial comparing nivolumab versus everolimus in previously treated advanced or metastatic clear-cell renal cell carcinoma has compl…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
This clinical trial update reports a completed retrospective study of temsirolimus in renal cell carcinoma and mantle cell lymphoma. Results…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2 [Phase 2]
Phase 2 study of irradiated donor lymphocyte infusion plus high-dose interleukin-2 for metastatic melanoma and renal cell carcinoma was term…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies [Phase 1]
Phase 1 study of nivolumab (BMS-936558) in advanced or recurrent malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: AMG 172 First in Human Study in Patients With Kidney Cancer [Phase 1]
A first-in-human Phase 1 trial of AMG 172 in patients with kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib [Phase 2]
This document reports the completion of a Phase 2 trial of AMG 386 in combination with sorafenib for first-line advanced renal cell carcinom…
-
CLINICAL_TRIALS trial_result · 2016-03-21Clinical Trial Update: Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal [Phase 2]
Phase 2 trial update on Everolimus (RAD001) for advanced renal cell carcinoma prior to nephrectomy; the study was terminated with results po…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal Cancer [Phase 2]
Phase 2 safety study comparing TroVax alone versus TroVax plus Interferon Alpha in patients with renal cell carcinoma; the trial status is c…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer [Phase 2]
This update summarizes a completed Phase 2 safety and toxicity study of sorafenib in patients with renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 safety study evaluating RAD001 (everolimus) in patients with metastatic renal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer [Phase 2]
The Phase 2 safety study evaluating a tumor-targeting drug plus an immune therapy for renal cell carcinoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase I/II study evaluating the combination of RAD001 (everolimus) and Nexavar (soraf…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Study of Pegylated Alfa Interferon, Sunitinib and Tarceva in Patients With Metastatic RCC [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pegylated alfa interferon, sunitinib, and tarceva in patients with metastatic renal cell carcinoma has…
-
CLINICAL_TRIALS trial_result · 2016-03-15Clinical Trial Update: Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy [NA]
A completed study evaluating contrast-enhanced intraoperative ultrasound for detecting and characterizing renal masses during open partial n…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Efficacy of Ultrasound Contrast Agent to Assess Renal Masses [Phase 2]
Phase 2 clinical trial evaluating the efficacy of an ultrasound contrast agent for assessing renal masses, including renal cell carcinoma, h…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer
This completed clinical trial investigates quantitative imaging metrics from contrast-enhanced CT (CECT) to measure disease response or prog…